$GILD Recent Headlines Long view on stocks is
Post# of 74540
Posted On: 04/21/2014 9:57:34 AM
$GILD Recent Headlines
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
UnitedHealth already seeing effects of Gilead's pricey hepatitis C drug 5:54 p.m. April 17, 2014 - blogs.marketwatch.com
4 reasons the first quarter was better than it appeared 6:20 a.m. April 17, 2014 - Tim Clift
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Saumya Vaishampayan
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - blogs.marketwatch.com
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Toss these investments as part of spring cleaning 6:00 a.m. April 10, 2014 - Jeff Reeves
First Solar tops S&P 500; Alcoa up ahead of earnings 3:51 p.m. April 8, 2014 - Ben Eisen
Gilead hepatitis C drug to get FDA priority review 9:40 a.m. April 7, 2014 - MarketWatch.com
Gilead: Hepatitis C Japan trial meets endpoint 3:43 a.m. April 3, 2014 - MarketWatch.com
Facebook, Biogen, Cal-Maine are stocks to watch 5:21 a.m. March 31, 2014 - Victor Reklaitis
Play-it-safe stock investors may take some risk on jobs 8:30 a.m. March 30, 2014 - Wallace Witkowski
U.S. stocks end week with losses 7:17 p.m. March 28, 2014 - Anora Mahmudova
Bombora watch, the 'momo' chart of pain and 5 reasons to buy Citigroup 8:33 a.m. March 28, 2014 - blogs.marketwatch.com
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - blogs.marketwatch.com
Nasdaq slumps 1.2%, but Dow dips just 0.2%: Stock market live blog recap 3:39 p.m. March 24, 2014 - blogs.marketwatch.com
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - blogs.marketwatch.com
J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside 8:39 a.m. Today - 247WallSt.com
Weekly Insider Sells Highlight: ATHN, GILD, JPM, WAG 10:06 p.m. April 20, 2014 - GuruFocus.com
Excellent Earnings, Tough Audience, Surprises Among the Leaders: Jim Cramer's Best Blogs 6:00 a.m. April 19, 2014 - TheStreet.com
Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings 11:12 a.m. April 18, 2014 - Investors Business Daily
UnitedHealth Earnings Drop on ObamaCare, Medicare Cuts 5:13 p.m. April 17, 2014 - Investors Business Daily
Has A Streamlined FDA Raised The Value Of Drug Stocks? 4:33 p.m. April 17, 2014 - Investors Business Daily
After Shaky Start, Weibo Jumps in Nasdaq Debut 4:00 p.m. April 17, 2014 - FOXBusiness
Today's Top Performers In Drugs 1:03 p.m. April 17, 2014 - TheStreet.com
UnitedHealth's Profit Falls Amid Health-Law Changes 11:33 a.m. April 17, 2014 - The Wall Street Journal Interactive Edition
Managers See Buys in Choppy Markets, Including Gilead, LinkedIn 9:41 a.m. April 17, 2014 - TheStreet.com
Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings 9:18 a.m. April 17, 2014 - TheStreet.com
Ready For A Rebound? Gilead's $1000 Pill 7:38 a.m. April 17, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ALXN MRK GILD XRAY 7:30 a.m. April 17, 2014 - InvestorPlace.com
Rolling The Dice With Earnings 5:29 p.m. April 16, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: EBAY, GS, GILD 3:14 p.m. April 16, 2014 - TheStreet.com
Gilead Sciences May See A Healthy Earnings Beat 1:35 p.m. April 16, 2014 - Seeking Alpha
IPOs: 4 Stocks To Buy After The Plunge 10:08 a.m. April 16, 2014 - InvestorPlace.com
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog 10:07 a.m. April 16, 2014 - Zacks.com
Why Gilead Sciences Inc. (GILD) Stock Might be a Great Pick - Tale of the Tape 8:32 a.m. April 16, 2014 - Zacks.com
3 Pharmaceuticals to Profit on Obamacare 6:34 a.m. April 16, 2014 - InvestorPlace.com
Young Scientists From Around the State Will Compete for Top Honors at the 63rd California State Science Fair 6:31 p.m. April 16, 2014 - PR Newswire - PRF
Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014 5:00 p.m. April 15, 2014 - BusinessWire - BZX
AHF: Anti-Gilead Drug Pricing Campaign Picks Up Steam 2:24 p.m. April 14, 2014 - BusinessWire - BZX
Financial Release Dates -- Research on Gilead Sciences, Juniper Networks, FirstCommonwealth Financial, and Genuine Parts 9:00 a.m. April 14, 2014 - PR Newswire - PRF
Final Data from the Phase 2 COSMOS Study of Janssen’s Once-Daily Simeprevir in Combination with Sofosbuvir Presented at the International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:24 a.m. April 12, 2014 - BusinessWire - BZX
Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir in Combination with Sofosbuvir Presented at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:15 a.m. April 12, 2014 - PR Newswire - PRF
Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir in Combination with Sofosbuvir Presented at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:15 a.m. April 12, 2014 - PR Newswire - PRF
Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest 10:14 a.m. April 11, 2014 - PR Newswire - PRF
Today's Review on Active Stocks -- Research on Ashford Hospitality Trust, Dejour Energy, North American Palladium, and Gilead Sciences 1:30 p.m. April 10, 2014 - PR Newswire - PRF
Emerging Therapies in Development for Relapsed/Refractory CLL/SLL are Expected to Offer Efficacy Benefits Over Currently Available Treatments 10:00 a.m. April 10, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Results for Two Investigational All-Oral Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C 1:02 a.m. April 10, 2014 - BusinessWire - BZX
Clinical Trial Results Presentation and Publication, and Upcoming Exhibit - Analyst Notes on Gilead Sciences, Agios, Mindray, BG Medicine, and Ultragenyx 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Gilead Announces U.S. FDA Priority Review Designation for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Chronic Hepatitis C Genotype 1 Infection 8:31 a.m. April 7, 2014 - BusinessWire - BZX
Senior Notes Conversions, FDA Drug Approvals, Acquisitions, Stock Price Updates, and Clinical Trial Studies - Analyst Notes on Gilead, Pfizer, Nordion, Intuitive Surgical, and Novartis 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Gilead Announces Results From Phase 3 Study of Sofosbuvir Among Hepatitis C Patients in Japan 4:30 p.m. April 2, 2014 - BusinessWire - BZX
Critical Alerts For Ford, Castlight Health, Gilead Sciences, Take Two Interactive, and Qihoo 360 Released By InvestorsObserver 9:31 a.m. April 2, 2014 - PR Newswire - PRF
Pending Applications, Closed Public Offering, Joint Venture Formation, Executive Appointment, and Commercial Launch - Analyst Notes on Gilead, Enzymotec, Intrexon, Advaxis, and Repligen 8:00 a.m. April 1, 2014 - PR Newswire - PRF
Comprehensive Technical Coverage on Active Equities -- Research on Sirius XM, Gilead Sciences, Microsoft, and Yahoo! 12:03 p.m. March 31, 2014 - PR Newswire - PRF
Gilead Announces Settlement Method for 1.00% Convertible Senior Notes Due 2014 8:30 a.m. March 28, 2014 - BusinessWire - BZX
Gilead's Marketing Application Validated by EMA; Accenture Misses Zack's Consensus Estimate 12:38 a.m. March 28, 2014 - ACCESSWIRE
Long view on stocks is best during weak earnings season 6:00 a.m. April 20, 2014 - Wallace Witkowski
UnitedHealth already seeing effects of Gilead's pricey hepatitis C drug 5:54 p.m. April 17, 2014 - blogs.marketwatch.com
4 reasons the first quarter was better than it appeared 6:20 a.m. April 17, 2014 - Tim Clift
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Saumya Vaishampayan
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - blogs.marketwatch.com
Merck: Hepatitis C drug has 98% cure rate in trial 11:43 a.m. April 10, 2014 - MarketWatch.com
Toss these investments as part of spring cleaning 6:00 a.m. April 10, 2014 - Jeff Reeves
First Solar tops S&P 500; Alcoa up ahead of earnings 3:51 p.m. April 8, 2014 - Ben Eisen
Gilead hepatitis C drug to get FDA priority review 9:40 a.m. April 7, 2014 - MarketWatch.com
Gilead: Hepatitis C Japan trial meets endpoint 3:43 a.m. April 3, 2014 - MarketWatch.com
Facebook, Biogen, Cal-Maine are stocks to watch 5:21 a.m. March 31, 2014 - Victor Reklaitis
Play-it-safe stock investors may take some risk on jobs 8:30 a.m. March 30, 2014 - Wallace Witkowski
U.S. stocks end week with losses 7:17 p.m. March 28, 2014 - Anora Mahmudova
Bombora watch, the 'momo' chart of pain and 5 reasons to buy Citigroup 8:33 a.m. March 28, 2014 - blogs.marketwatch.com
Nasdaq pullback rife with opportunity 2:07 p.m. March 25, 2014 - The Trading Deck
Biotech comeback stalls as Wall Street starts to worry 12:45 p.m. March 25, 2014 - blogs.marketwatch.com
Nasdaq slumps 1.2%, but Dow dips just 0.2%: Stock market live blog recap 3:39 p.m. March 24, 2014 - blogs.marketwatch.com
Biotech has second straight sell-off; sector mutual funds take it on chin 10:40 a.m. March 24, 2014 - blogs.marketwatch.com
Biotech's Friday selloff: Are sector bears growling or just stretching? 5:08 p.m. March 21, 2014 - blogs.marketwatch.com
J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside 8:39 a.m. Today - 247WallSt.com
Weekly Insider Sells Highlight: ATHN, GILD, JPM, WAG 10:06 p.m. April 20, 2014 - GuruFocus.com
Excellent Earnings, Tough Audience, Surprises Among the Leaders: Jim Cramer's Best Blogs 6:00 a.m. April 19, 2014 - TheStreet.com
Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings 11:12 a.m. April 18, 2014 - Investors Business Daily
UnitedHealth Earnings Drop on ObamaCare, Medicare Cuts 5:13 p.m. April 17, 2014 - Investors Business Daily
Has A Streamlined FDA Raised The Value Of Drug Stocks? 4:33 p.m. April 17, 2014 - Investors Business Daily
After Shaky Start, Weibo Jumps in Nasdaq Debut 4:00 p.m. April 17, 2014 - FOXBusiness
Today's Top Performers In Drugs 1:03 p.m. April 17, 2014 - TheStreet.com
UnitedHealth's Profit Falls Amid Health-Law Changes 11:33 a.m. April 17, 2014 - The Wall Street Journal Interactive Edition
Managers See Buys in Choppy Markets, Including Gilead, LinkedIn 9:41 a.m. April 17, 2014 - TheStreet.com
Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings 9:18 a.m. April 17, 2014 - TheStreet.com
Ready For A Rebound? Gilead's $1000 Pill 7:38 a.m. April 17, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – ALXN MRK GILD XRAY 7:30 a.m. April 17, 2014 - InvestorPlace.com
Rolling The Dice With Earnings 5:29 p.m. April 16, 2014 - Seeking Alpha
3 Stocks Reiterated As A Buy: EBAY, GS, GILD 3:14 p.m. April 16, 2014 - TheStreet.com
Gilead Sciences May See A Healthy Earnings Beat 1:35 p.m. April 16, 2014 - Seeking Alpha
IPOs: 4 Stocks To Buy After The Plunge 10:08 a.m. April 16, 2014 - InvestorPlace.com
Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog 10:07 a.m. April 16, 2014 - Zacks.com
Why Gilead Sciences Inc. (GILD) Stock Might be a Great Pick - Tale of the Tape 8:32 a.m. April 16, 2014 - Zacks.com
3 Pharmaceuticals to Profit on Obamacare 6:34 a.m. April 16, 2014 - InvestorPlace.com
Young Scientists From Around the State Will Compete for Top Honors at the 63rd California State Science Fair 6:31 p.m. April 16, 2014 - PR Newswire - PRF
Gilead Sciences to Release First Quarter 2014 Financial Results on Tuesday, April 22, 2014 5:00 p.m. April 15, 2014 - BusinessWire - BZX
AHF: Anti-Gilead Drug Pricing Campaign Picks Up Steam 2:24 p.m. April 14, 2014 - BusinessWire - BZX
Financial Release Dates -- Research on Gilead Sciences, Juniper Networks, FirstCommonwealth Financial, and Genuine Parts 9:00 a.m. April 14, 2014 - PR Newswire - PRF
Final Data from the Phase 2 COSMOS Study of Janssen’s Once-Daily Simeprevir in Combination with Sofosbuvir Presented at the International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:24 a.m. April 12, 2014 - BusinessWire - BZX
Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir in Combination with Sofosbuvir Presented at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:15 a.m. April 12, 2014 - PR Newswire - PRF
Final Data from the Phase 2 COSMOS Study of Janssen's Once-Daily Simeprevir in Combination with Sofosbuvir Presented at The International Liver Congress™ 2014 of the European Association for the Study of the Liver (EASL) 11:15 a.m. April 12, 2014 - PR Newswire - PRF
Priority Reviews, Preliminary Earnings Releases, Clinical Trials Results, and Launch of Website - Analyst Notes on Gilead, Pfizer, Intuitive Surgical, Alkermes and Quest 10:14 a.m. April 11, 2014 - PR Newswire - PRF
Today's Review on Active Stocks -- Research on Ashford Hospitality Trust, Dejour Energy, North American Palladium, and Gilead Sciences 1:30 p.m. April 10, 2014 - PR Newswire - PRF
Emerging Therapies in Development for Relapsed/Refractory CLL/SLL are Expected to Offer Efficacy Benefits Over Currently Available Treatments 10:00 a.m. April 10, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Results for Two Investigational All-Oral Sofosbuvir-Based Regimens for the Treatment of Chronic Hepatitis C 1:02 a.m. April 10, 2014 - BusinessWire - BZX
Clinical Trial Results Presentation and Publication, and Upcoming Exhibit - Analyst Notes on Gilead Sciences, Agios, Mindray, BG Medicine, and Ultragenyx 8:00 a.m. April 9, 2014 - PR Newswire - PRF
Gilead Announces U.S. FDA Priority Review Designation for Ledipasvir/Sofosbuvir Fixed-Dose Combination Tablet for Chronic Hepatitis C Genotype 1 Infection 8:31 a.m. April 7, 2014 - BusinessWire - BZX
Senior Notes Conversions, FDA Drug Approvals, Acquisitions, Stock Price Updates, and Clinical Trial Studies - Analyst Notes on Gilead, Pfizer, Nordion, Intuitive Surgical, and Novartis 8:00 a.m. April 3, 2014 - PR Newswire - PRF
Gilead Announces Results From Phase 3 Study of Sofosbuvir Among Hepatitis C Patients in Japan 4:30 p.m. April 2, 2014 - BusinessWire - BZX
Critical Alerts For Ford, Castlight Health, Gilead Sciences, Take Two Interactive, and Qihoo 360 Released By InvestorsObserver 9:31 a.m. April 2, 2014 - PR Newswire - PRF
Pending Applications, Closed Public Offering, Joint Venture Formation, Executive Appointment, and Commercial Launch - Analyst Notes on Gilead, Enzymotec, Intrexon, Advaxis, and Repligen 8:00 a.m. April 1, 2014 - PR Newswire - PRF
Comprehensive Technical Coverage on Active Equities -- Research on Sirius XM, Gilead Sciences, Microsoft, and Yahoo! 12:03 p.m. March 31, 2014 - PR Newswire - PRF
Gilead Announces Settlement Method for 1.00% Convertible Senior Notes Due 2014 8:30 a.m. March 28, 2014 - BusinessWire - BZX
Gilead's Marketing Application Validated by EMA; Accenture Misses Zack's Consensus Estimate 12:38 a.m. March 28, 2014 - ACCESSWIRE
(0)
(0)Scroll down for more posts ▼